Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bob Djavan

Urology

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Urology|September 6, 2003
Lower urinary tract symptoms/benign prostatic hyperplasia: fast control of the patient's quality of lifeBob Djavan
Urology|August 30, 2003
An artificial neural network to predict the outcome of repeat prostate biopsiesMesut Remzi, Theodore Anagnostou, Vincent Ravery, et al.
Urology|October 18, 2002
Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trialBob Djavan, Mesut Remzi, Alexandre R Zlotta, et al.
Urology|December 15, 2004
Longitudinal study of men with mild symptoms of bladder outlet obstruction treated with watchful waiting for four yearsBob Djavan, Yan Kit Fong, Mike Harik, et al.
Urology|July 17, 2012
Role of testosterone in managing advanced prostate cancerKyle O Rove, Frans M Debruyne, Bob Djavan, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Urology|September 6, 2003
Lower urinary tract symptoms/benign prostatic hyperplasia: fast control of the patient's quality of lifeBob Djavan
Urology|August 30, 2003
An artificial neural network to predict the outcome of repeat prostate biopsiesMesut Remzi, Theodore Anagnostou, Vincent Ravery, et al.
Urology|October 18, 2002
Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trialBob Djavan, Mesut Remzi, Alexandre R Zlotta, et al.
Urology|December 15, 2004
Longitudinal study of men with mild symptoms of bladder outlet obstruction treated with watchful waiting for four yearsBob Djavan, Yan Kit Fong, Mike Harik, et al.
Urology|July 17, 2012
Role of testosterone in managing advanced prostate cancerKyle O Rove, Frans M Debruyne, Bob Djavan, et al.
Pageof 1